Optimization Therapy by Coupling Intermittent Androgen Suppression with Impulsive Chemotherapy for a Prostate Cancer Model
Bulletin of Mathematical Biology · 2023
DOI: 10.1007/s11538-023-01228-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Mathematical Biology, 2023. Verfasst von Yongzhen Pei und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematical Sciences, Tiangong University, Tianjin, China. yzhpei@tiangong.edu.cn. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Intermittent androgen suppression in the prostate cancer is often relapsed by the increasing of prostate specific antigen level during the on-treatment. Historically, chemotherapy has had a limited role in the treatment of prostate cancer. However, new agents are showing promise in patients with advanced disease. Intermittent androgen suppression plus chemotherapy in pulsed pattern has become an indispensable clinical scheme for prostate cancer, which is presented to describe the transformation mechanism for three kinds of cancer cells in this paper. The model is then extended to include the residual effect of chemotherapy which suppresses the cancer cells production, thereby preventing the relapse. The optimal controls represent the efficiencies of both intermittent androgen suppression and chemotherapy in suppressing relapse of prostate cancer. Based on an optimal algorithm, numerical simulations are implemented not only to show the optimal durations of on- and off-treatment and chemotherapy dosages but also to present the effectiveness of different strategies in inhibiting the relapse for three types of patients. Results reveal that the optimal intermittent androgen suppression scheme with alterable treatment cycles is pivotal for type I and II patients, in part because it can greatly reduce the on-treatment time and degrade the level of prostate specific antigen. Furthermore, optimal hybrid schedule even averts the relapse of prostate cancer for type II and III patients. Finally, comparing the prostate specific antigen under intermittent androgen suppression schedule with residual effect of chemotherapy to one without residual effect of chemotherapy demonstrates the validity of both our model and algorithms in lessening the prostate specific antigen and decreasing the chemotherapy dosages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Mathematical Sciences, Tiangong University, Tianjin, China. yzhpei@tiangong.edu.cn.
- School of Mathematical Sciences, Tiangong University, Tianjin, China.
- Department of Basic Science, Army Military Transportation University, Tianjin, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pei, Y., Lv, Y., Li, C., & Fang, D. (2023). Optimization Therapy by Coupling Intermittent Androgen Suppression with Impulsive Chemotherapy for a Prostate Cancer Model. Bulletin of Mathematical Biology. https://doi.org/10.1007/s11538-023-01228-2
Vancouver
Pei Y, Lv Y, Li C, Fang D. Optimization Therapy by Coupling Intermittent Androgen Suppression with Impulsive Chemotherapy for a Prostate Cancer Model. Bulletin of Mathematical Biology. 2023. doi:10.1007/s11538-023-01228-2
BibTeX
@article{Pei2023,
author = {Pei, Yongzhen and Lv, Yunfei and Li, Changguo and Fang, Dandan},
title = {Optimization Therapy by Coupling Intermittent Androgen Suppression with Impulsive Chemotherapy for a Prostate Cancer Model},
journal = {Bulletin of Mathematical Biology},
year = {2023},
doi = {10.1007/s11538-023-01228-2}
}
EUVIMED